1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32 | Facility records revealed R1’s prescription of Permethrin arrived later that evening and facility staff administered the ointment as directed, Facility staff also administered a second dose of the ointment on May 29, 2022 as directed. An interview with facility staff also revealed R1's clothing, bedding, mattress, and rug was cleaned per protocol. A record review of facility protocol for scabies revealed procedures were followed by policy.
It was also alleged facility staff did not use PPE equipment properly. An interview with an outside source (OS1) revealed facility staff was using the same PPE between R1 and Resident2 (R2) while R1 was being treated for scabies, and R2 had a contagious bacterial infection. An interview with an outside source (OS2) revealed around May 6, 2020 R2 had just returned from a hospital stay due to an unrelated health condition. R2’s Responsible Party had hired a 24 hour private companion to assist with R2’s needs. OS2 also revealed R2 had a private apartment with a private bathroom. During that time, due to R2's health condition, facility staff only came to R2’s room to deliver meals and provide medications per infection control protocol. Interviews with an outside source (OS3's) statement revealed new PPE was always used when entering either of the resident's rooms. OS3 also revealed due to the private companion staff had minimal contact with R2, and only provided meals and/or medication to R2. OS3 also revealed facility staff never reused the same PPE equipment across residents.
Due to lack of corroborating evidence, the finding regarding the above allegations were established to be unsubstantiated. This finding means although the allegations may have happened, or could be valid, there is not a preponderance of evidence to prove that the alleged violations occurred.
An exit interview was conducted with ED Armour and a copy of the Complaint Investigation Report (LIC 9099) and Licensee Rights (LIC 9058 01-2016) was provided to ED Armour, and signature on this report acknowledges receipt of the reports. |